Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology.Eur Heart J. 2013; 34: 2949-3003
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Circulation. 2012; 126: e354-e471
- 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation. 2013; 127: e362-e425
- Exercise-based cardiac rehabilitation for coronary heart disease: cochrane systematic review and meta-analysis.J Am Coll Cardiol. 2016; 67: 1-12
- Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: the 2005 French FAST-MI study.Arch Cardiovasc Dis. 2016; 109: 178-187
- Prevalence of cardiovascular risk factors in men with stable coronary heart disease in France and Spain.Arch Cardiovasc Dis. 2010; 103: 80-89
- Prognostic usefulness of clinical and subclinical peripheral arterial disease in men with stable coronary heart disease.Am J Cardiol. 2012; 110: 197-202
- Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study.J Lipid Res. 2013; 54: 2550-2558
- Association of hepatic lipase -514T allele with coronary artery disease and ankle-brachial index, dependence on the lipoprotein phenotype: the GENES study.PLoS One. 2013; 8: e67805
- Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study.BMC Med. 2016; 14: 125
- Serum inhibitory factor 1, high-density lipoprotein and cardiovascular diseases.Curr Opin Lipidol. 2017; 28: 337-346
- Common p2y13 polymorphisms are associated with plasma inhibitory factor 1 and lipoprotein(a) concentrations, heart rate and body fat mass: the GENES study.Arch Cardiovasc Dis. 2019; 112: 124-134
- A more meaningful scoring system for determining the severity of coronary heart disease.Am J Cardiol. 1983; 51: 606
- Validity and reliability in a Flemish population of the WHO-MONICA Optional Study of Physical Activity Questionnaire.Med Sci Sports Exerc. 1998; 30: 1071-1075
- A collection of Physical Activity Questionnaires for health-related research.Med Sci Sports Exerc. 1997; 29: S1-205
- Physical activity and mortality in older men with diagnosed coronary heart disease.Circulation. 2000; 102: 1358-1363
- Influence of physical activity on mortality in elderly with coronary artery disease.Med Sci Sports Exerc. 2006; 38: 418-427
- Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease.Am J Cardiol. 2008; 102: 375-379
- Physical activity and mortality in patients with stable coronary heart disease.J Am Coll Cardiol. 2017; 70: 1689-1700
- Sustained physical activity, not weight loss, associated with improved survival in coronary heart disease.J Am Coll Cardiol. 2018; 71: 1094-1101
- Exercise-based cardiac rehabilitation for adults with heart failure.Cochrane Database Syst Rev. 2019; 1 (CD003331)
- 10-year exercise training in chronic heart failure: a randomized controlled trial.J Am Coll Cardiol. 2012; 60: 1521-1528
- Effect of changes in physical activity on risk for cardiac death in patients with coronary artery disease.Am J Cardiol. 2018; 121: 143-148
Sources of funding: The GENES study was supported by grants from Toulouse University Hospital ( AOL-99-13-L , DRC), INSERM , the Fédération Française de Cardiologie , and the Fondation de France .
The sponsor had no role in study design, nor in the collection, analysis and interpretation of data, nor in writing the report and in the decision to submit the article for publication.